Pasatru
Active substance: garetosmab
INJECTION, SOLUTION, CONCENTRATE · GARETOSMAB 300 mg/5mL
United StatesActive
Marketing holder: Regeneron Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GARETOSMAB · 300 mg/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8751-733f-9c49-09ebf34c7962;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 61755-012
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 61755-012 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61755-012 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61755-012 · Verified 2026-10-09 · open in source